Who is sponsoring NCT05971004?

NCT05971004 is sponsored by Tiss'You srl.

What drugs are being tested in NCT05971004?

Interventions in NCT05971004: Arthrys (Collagen Peptide solution), Depo medrol.

What condition does NCT05971004 study?

NCT05971004 studies Collateral Ligament Injury of Stifle Joint.

Is NCT05971004 still recruiting?

NCT05971004 is currently completed. Last updated 2 August 2023.

Last reviewed 2023-08-02 · How we verify

NCT05971004

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Hydrolyzed Collagen Peptide Injection for the Treatment of Collateral Ligament Pain

Completed NA Last updated 2 August 2023

What this trial tests

NA trial testing Arthrys (Collagen Peptide solution) in Collateral Ligament Injury of Stifle Joint in 62 participants. Completed in 4 April 2023.

Timeline

13 April 2022

Primary endpoint
10 October 2022

4 April 2023

Quick facts

Lead sponsor	Tiss'You srl
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	62
Start date	13 April 2022
Primary completion	10 October 2022
Estimated completion	4 April 2023
Sites	1 location across San Marino

Drugs / interventions tested

Arthrys (Collagen Peptide solution)
Depo medrol

Conditions studied

Collateral Ligament Injury of Stifle Joint — all drugs for Collateral Ligament Injury of Stifle Joint →

Sponsor

Tiss'You srl

Who can join

18 and older, any sex, with Collateral Ligament Injury of Stifle Joint. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Conducted by Binh Luu Thi, Lan Tran Thi, and Minh Hang Hoang Thi at Thai Nguyen National Hospital, the study investigates a new approach to treating persistent collateral ligament pain, common among athletes. The research examines the therapeutic use of hydrolyzed collagen peptide injections, a treatment that addresses pain and inflammation in ways previous methods have not. The study involves a randomized controlled trial with 62 patients, all diagnosed with inflammation in the collateral ligament site. The patients are split into two groups: one receiving collagen injections alongside oral painkillers and the other receiving depo-medrol injections with oral painkillers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05971004 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tiss'You srl
Last refreshed: 2 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05971004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing